Go to content
UR Home

Zelltherapie am Augenhintergrund – gestern, heute, morgen

Brandl, Caroline (2017) Zelltherapie am Augenhintergrund – gestern, heute, morgen. medizinische genetik 29 (2), pp. 208-216.

Full text not available from this repository.

at publisher (via DOI)

Other URL: http://doi.org/10.1007/s11825-017-0140-8


Abstract

The endpoint of most retinal degenerative disorders is a loss of cells in the retinal pigment epithelium and/or the neurosensory retina, leading to irreversible visual impairment. Therefore, therapeutic strategies in the late disease stages also need to address the replacement of lost cells or tissues. In recent years, rapid advances have been made in the field of stem cell-based cellular ...

plus


Export bibliographical data



Item type:Article
Date:2017
Institutions:Medicine > Lehrstuhl für Augenheilkunde
Medicine > Lehrstuhl für Humangenetik
Medicine > Institut für Epidemiologie und Präventivmedizin > Lehrstuhl für Genetische Epidemiologie
Identification Number:
ValueType
10.1007/s11825-017-0140-8DOI
Keywords:PLURIPOTENT STEM-CELLS; RETINAL-PIGMENT EPITHELIUM; AGE-RELATED MACULOPATHY; MACULAR DEGENERATION; OPHTHALMOLOGY TREATMENT; CLINICAL-TRIAL; DYSTROPHIES; RPE; SYSTEM; SCOTS; Retinal dystrophy; Age-related macular degeneration; Induced pluripotent stem cells; Retinal pigment epithelium; Haplobank
Dewey Decimal Classification:600 Technology > 610 Medical sciences Medicine
Status:Published
Refereed:Yes, this version has been refereed
Created at the University of Regensburg:Yes
Item ID:38911
Owner only: item control page
  1. Homepage UR

University Library

Publication Server

Contact:

Publishing: oa@ur.de

Dissertations: dissertationen@ur.de

Research data: daten@ur.de

Contact persons